Osvaldo Rivera-Gonzalez

Osvaldo Rivera-Gonzalez

Auto-generated profile, based on publicly available information

Osvaldo Rivera-Gonzalez

Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2026 in Science Advances
Verified
Journal Article
Open access
OROsvaldo Rivera-Gonzalez
Osvaldo Rivera-Gonzalez
LLLiu Liu
Liu Liu
FGFiona M. Gribble
Fiona M. Gribble
FRFrank Reimann
Frank Reimann
JWJurgen Wess
Jurgen Wess
Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone that promotes postprandial insulin release and euglycemia. Although GIP is the dominant incretin in humans, the precise mechanisms regulating GIP release from enteroendocrine K cells in vivo remain to be elucidated. Heterotrimeric G proteins of the G i family regulate numerous key physiological functions. To explore the potential role of these proteins in modulating K cell function in vivo, we analyzed mutant mice that allowed us to selectively stimulate G i signaling in K cells or studied mice lacking functional G i in K cells only. Stimulation of K cell G i signaling in vivo and in vitro led to reduced GIP release via an exchange protein directly activated by 3ʹ-5ʹ-cyclic adenosine monophosphate 2–dependent pathway and various metabolic deficits. In contrast, inactivation of this class of G proteins in K cells caused elevated plasma GIP levels and pronounced improvements in glucose homeostasis in lean and obese mice. These data provide important insights into the mechanisms of GIP release.